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ABSTRACT
ObjeCtive
To determine the risks of stillbirth and neonatal 
complications by gestational age in uncomplicated 
monochorionic and dichorionic twin pregnancies.
Design
Systematic review and meta-analysis.
Data sOurCes
Medline, Embase, and Cochrane databases (until 
December 2015). 
review methODs
Databases were searched without language restrictions 
for studies of women with uncomplicated twin 
pregnancies that reported rates of stillbirth and neonatal 
outcomes at various gestational ages. Pregnancies with 
unclear chorionicity, monoamnionicity, and twin to twin 
transfusion syndrome were excluded. Meta-analyses of 
observational studies and cohorts nested within 
randomised studies were undertaken. Prospective risk of 
stillbirth was computed for each study at a given week of 
gestation and compared with the risk of neonatal death 
among deliveries in the same week. Gestational age 
specific differences in risk were estimated for stillbirths 
and neonatal deaths in monochorionic and dichorionic 
twin pregnancies after 34 weeks’ gestation.
results
32 studies (29 685 dichorionic, 5486 monochorionic 
pregnancies) were included. In dichorionic twin 
pregnancies beyond 34 weeks (15 studies, 17 830 
pregnancies), the prospective weekly risk of stillbirths 
from expectant management and the risk of neonatal 
death from delivery were balanced at 37 weeks’ 
gestation (risk difference 1.2/1000, 95% confidence 
interval −1.3 to 3.6; I2=0%). Delay in delivery by a week 
(to 38 weeks) led to an additional 8.8 perinatal deaths 
per 1000 pregnancies (95% confidence interval 3.6 to 
14.0/1000; I2=0%) compared with the previous week. 
In monochorionic pregnancies beyond 34 weeks (13 
studies, 2149 pregnancies), there was a trend towards 
an increase in stillbirths compared with neonatal 
deaths after 36 weeks, with an additional 2.5 per 1000 
perinatal deaths, which was not significant (−12.4 to 
17.4/1000; I2=0%). The rates of neonatal morbidity 
showed a consistent reduction with increasing 
gestational age in monochorionic and dichorionic 
pregnancies, and admission to the neonatal intensive 
care unit was the commonest neonatal complication. 
The actual risk of stillbirth near term might be higher 
than reported estimates because of the policy of 
planned delivery in twin pregnancies.
COnClusiOns
To minimise perinatal deaths, in uncomplicated 
dichorionic twin pregnancies delivery should be 
considered at 37 weeks’ gestation; in monochorionic 
pregnancies delivery should be considered at 36 weeks.
systematiC review registratiOn
PROSPERO CRD42014007538.
Introduction
Twin pregnancies are high risk, with a thirteenfold 
increase in rates of stillbirth in monochorionic and a 
fivefold increase in dichorionic twins compared with 
singleton pregnancies.1-3  Uncomplicated twin pregnan-
cies are often delivered early in an attempt to prevent 
late stillbirth. Delivery before term is associated with 
neonatal complications associated with prematurity.1 
Since 2005, the number of patient safety incidents 
involving multiple pregnancies, including unexpected 
stillbirth and neonatal death, has risen by 419% in UK, 
and peaked in 2013-14, resulting in payouts of over 
£90m ($117m, €105m).4 5  The recent global drive to pre-
vent stillbirth has highlighted multiple pregnancy as a 
major risk factor in high income countries,6  with calls 
to prioritise evaluation of timing of delivery and out-
comes in twin pregnancies.7
WhAT IS AlReAdy knoWn on ThIS TopIC
The risk of stillbirth is higher in twin pregnancies than in singleton pregnancies
Risk increases with advancing gestational age in uncomplicated monochorionic 
and dichorionic twin pregnancies
WhAT ThIS STudy AddS
For women with dichorionic twin pregnancies, delivery should be considered at 
37 weeks’ gestation to prevent the significant increase in stillbirths associated with 
expectant management compared with the risk of neonatal deaths associated with 
early delivery
In monochorionic twin pregnancies, there is no clear evidence to support routine 
delivery before 36 weeks’ gestation
Gestation specific risks of neonatal outcomes in early preterm twin gestations could 
aid in the counselling of mothers at risk of early preterm delivery
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The optimal gestational age for delivery that mini-
mises fetal and neonatal complications in twin preg-
nancies is not known. Current recommendations vary 
on the timing of delivery, starting from 34 up to 37 
weeks’ gestation in monochorionic twin pregnancies8 
and from 37 up to 39 weeks in dichorionic twin preg-
nancies.9-12  Women and their partners, clinicians, and 
guideline makers need robust estimates of the risk of 
stillbirth from continuing the pregnancy and the neo-
natal risk from early delivery to decide on the optimal 
timing of delivery. Existing reviews have focused mainly 
on the risk of stillbirth, without taking neonatal out-
comes into account.13  There are no published data on 
perinatal mortality and morbidity for specific gesta-
tions and chorionicity in twins to guide decision mak-
ing on the timing of delivery.14  Furthermore, 
randomised trials on timing are not adequately pow-
ered to provide robust estimates of benefit.15 16
We summarised data from individual studies to 
quantify the prospective risks of stillbirth in women 
with uncomplicated monochorionic and dichorionic 
twin pregnancies, as well as the risks to the newborn, 
when delivered after 34 weeks’ gestation and at various 
gestational ages.
Methods
We conducted the systematic review based on a pro-
spective protocol17  and reported according to the Pre-
ferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) guidelines).18
identification of studies
We searched the major electronic databases Medline, 
Embase, and Cochrane Library using the NHS Evidence 
website and Cochrane online library platforms from 
inception until December 2015 for studies on twin preg-
nancies that reported rates of stillbirth. Search terms 
representing the participants (‘monochorionic’ OR 
‘dichorionic’ OR ‘twin pregnancy’ OR ‘multiple preg-
nancy’) were combined with outcome terms (‘stillbirth’ 
OR (‘fetal or foetal or fetus or foetus’ AND ‘death or 
demise or mortality’)). We supplemented this search 
with an additional search for neonatal outcomes in 
twin pregnancies (appendix 1). We searched the refer-
ence lists of included studies. There were no language 
restrictions. Additionally, we contacted individual 
authors members of the collaborative research net-
works such as Global Obstetric Network (GONet),19  Evi-
dence Based Medicine Connect (EBM Connect),20  and 
the Twin pregnancies Individual Participant Data (IPD) 
Meta-Analysis group for relevant data.21
study selection
Two independent reviewers (FC-S and ES) used a two 
stage process to select the studies. In the first stage, 
they assessed abstracts and titles of citations for their 
eligibility. In the second stage, we obtained the full 
texts of the studies that seemed to fulfil the inclusion 
criteria for evaluation.
We included observational cohort studies and 
cohorts nested in randomised studies on rates of still-
birth or neonatal outcomes in monochorionic and/or 
dichorionic twin pregnancies. Exclusion criteria were 
unclear chorionicity, monoamnionicity, inability to 
exclude twin to twin transfusion syndrome in fetuses, 
and outcomes not provided in weekly or two weekly 
gestational periods.
We defined stillbirth as a baby born without signs of 
life after the age of viability or any other definition used 
by the authors. Neonatal mortality was defined as death 
up to 28 days after delivery. For infants born after 34 com-
pleted weeks of gestation, we considered the  following 
morbidity outcomes to be clinically relevant: need for 
assisted ventilation, respiratory distress syndrome, sep-
ticaemia, hypoxic ischaemic encephalopathy or neona-
tal seizures, and admission to the neonatal intensive care 
unit. For preterm infants born between 26 and 33+6 
weeks’ gestation, in addition to the above, we assessed 
the rates of bronchopulmonary dysplasia, necrotising 
enterocolitis, significantly abnormal results on cranial 
ultrasound scan (cystic periventricular leukomalacia or 
grade 3 or 4 intraventricular haemorrhage), and retinop-
athy of prematurity (stages 3 to 5) (appendix 2).
Quality assessment and data extraction
Two independent reviewers (FCS and ES) evaluated the 
quality of the studies by investigating separate parame-
ters for the internal validity (the extent to which the 
information is probably free from bias) and external 
validity (the representativeness of the population).22-24 
We evaluated individual parameters such as study 
design, method of sampling, adequacy of follow-up, 
ascertainment of the outcome, and appropriate deter-
mination of gestational age and chorionicity for inter-
nal validity. Studies with features such as prospective 
design, consecutive or random recruitment of patients, 
follow-up rates of over 80%, and use of signs on first 
trimester ultrasonography to determine chorionicity 
and gestational age were considered to have a low risk 
of bias. Studies without these features or with unclear 
reporting were classified to have high risk of bias. We 
categorised the studies with the following criteria to be 
highly representative for external validity: clear defini-
tion of uncomplicated twin pregnancies, exclusion of 
pregnancies in which one or both babies were diag-
nosed antenatally with growth restriction, or major con-
genital abnormalities. Any discrepancies were resolved 
after discussion with a third reviewer (ST).
analysis
We undertook separate analyses for risks of stillbirth 
and neonatal complications in monochorionic and 
dichorionic twin pregnancies in two periods: from 34 
weeks’ gestation and beyond and early preterm (<34 
weeks’) gestation. From 34 weeks onwards, we esti-
mated the risks by weekly gestational ages, with the 34 
week period representing pregnancies entering the 
34+0 to 34+6 weeks’ gestation with live fetuses, and so 
forth. For early preterm (<34 weeks’) gestation, we esti-
mated risks of outcomes by two weekly intervals.
We computed the weekly prospective risk of stillbirth 
by dividing the number of stillbirths observed at that 
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week by the number of women at risk in the same week. 
For a given gestational age, we defined women at risk of 
stillbirth as those who were still pregnant at the begin-
ning of the week. We corrected for deliveries in that week 
by subtracting half the number of women who delivered 
that week.25 For risk of neonatal death, we used a similar 
approach and divided the number of neonatal deaths 
observed by the number of deliveries that week.
In pregnancies beyond 34 weeks’ gestation, we 
assessed the competing risks of expectant management 
versus delivery at a particular gestational age for each 
study. We defined the risk of perinatal death at a given 
gestational week as the difference between risk of still-
birth and risk of neonatal death for deliveries in that 
week. This provided a direct measure of benefit or harm 
from expectant management versus immediate delivery 
strategy. A difference of less than zero indicates a reduc-
tion in the risk of perinatal death with expectant man-
agement at that gestational age compared with 
immediate delivery. We pooled risk differences from 
individual studies using a fixed effect model weighted 
by the inverse of its variance. We computed I2 as an esti-
mation of heterogeneity between studies and assumed 
values lower than 50% as little heterogeneity and I2 
greater than 75% as substantial heterogeneity.
We estimated the weekly risk of neonatal outcomes 
by fitting multilevel random effects logistic regression 
models with gestational age as the unique categorical 
independent variable. The units of the analysis were 
pregnancies (first level) that were clustered within stud-
ies (second level of the analysis). We obtained point 
estimates of the risk of each event by the gestational 
period with its corresponding 95% confidence interval. 
Before analysis we planned to restrict our evaluation up 
to the gestational week for which robust unbiased data 
were available.
Sensitivity analysis was planned before analysis to 
exclude studies involving pregnancies complicated by 
congenital abnormalities and those with low external 
validity. We assessed publication bias and small study 
effect using funnel plots representing overall event rate 
(logit scale) versus the inverse of sample size for each 
study included in main analysis.26  Peter’s test was used 
to evaluate funnel asymmetry by fitting a weighted lin-
ear regression with the logit of event rate as dependent 
variable and the inverse of sample size as independent 
variable. We computed weights according to the num-
ber of events and no events.27 We used a continuity cor-
rection for studies with no events by adding 0.5 to the 
events count and 1 to the total sample size.
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
developing plans for design or implementation of the 
study. No patients were asked to advise on interpreta-
tion or writing up of results. There are no plans to dis-
seminate the results of the research to study participants 
or the relevant patient community.
Results
identification of studies
From 2574 citations, we included 32 studies reporting 
on 35 171 women with twin gestations (29 685 dichori-
onic, 5486 monochorionic pregnancies) (fig 1 ).16 28-55 
Eighteen studies provided data on both monochorionic 
and dichorionic,16 30 32 34 36 38 40 42-45 48-51 54 56 57  seven on 
only monochorionic,29 31 37 39 41 47 53  and seven on only 
dichorionic twin pregnancies.28 33 35 46 52 55 58  Twenty 
three authors provided relevant unpublished 
data.16 28 30 32-35 38 39 41-43 47-54 56-58
Characteristics and quality of included studies
Fifteen studies on dichorionic pregnancies (17 830 
women) and 13 on monochorionic pregnancies (2149 
women) provided weekly stillbirth data after 34 weeks’ 
gestation. The corresponding neonatal death rates were 
provided by 13 (n=10 333) studies for dichorionic and 11 
(n=1461) for monochorionic pregnancies. Overall, 14 
studies excluded pregnancies complicated by fetal 
growth restriction, and 28 studies excluded pregnan-
cies with major congenital abnormalities. The diagno-
ses of fetal growth restriction and congenital 
abnormalities were made antenatally. Two studies 
reviewed the postmortem findings of stillborn babies 
for evidence of growth restriction. There were no major 
differences between the studies in the definitions of 
stillbirths, neonatal mortality, and morbidity outcomes 
(appendix 2). The number of stillbirths and neonatal 
deaths between 26 and 33+6 weeks and after 34 weeks’ 
gestation in individual studies for monochorionic and 
dichorionic pregnancies are provided in appendix 3.
The quality of the studies was adequately representa-
tive in 27 (27/32, 84%) and inadequately or unclearly 
Studies with data on
monochorionic twin
pregnancies only
(n=7; 1661 twin pregnancies)
Studies with data on
monochorionic and
dichorionic twin pregnancies
(n=18; 19 415 twin pregnancies)
Full texts retrieved (n=140)
Studies included in review (n=32; 35 171 twin pregnancies)
Studies with data on
dichorionic twin
pregnancies only
(n=7; 14 095 twin pregnancies)
Citations from Medline,
Embase, Cochrane electronic
databases from inception to
December 2015 (n=2574)
Other sources for neonatal
morbidity/mortality
data (n=14)
Additional data received
from authors (n=22)
Citations excluded aer review of
abstracts for eligibility (n=2470)
Excluded (n=108):
  No gestational specic data (n=31)
  Letters/reviews/case study/protocol (n=19)
  Unknown chorionicity (n=18)
  Duplicate data (n=16)
  Monoamniotic twins/triplets (n=6)
  Cannot extract data (n=5)
  Cannot exclude TTTS (n=10)
  Specic group (surviving twins) (n=3)
  Miscarriage outcome, not stillbirth (n=1)
Fig 1 | study selection process in systematic review on prospective risk of stillbirth and 
neonatal complications in uncomplicated twin pregnancies (tttt=twin to twin transfusion 
syndrome)
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representative in five (5/32, 16%) (fig 2). Fifteen of the 
included studies (15/32) were prospective, and, of these, 
12 (12/32, 38%) were nested cohorts in randomised tri-
als. Most studies used random or consecutive sampling 
methods (31/32, 97%), achieved adequate follow-up 
(26/32, 81%), and had low ascertainment bias in deter-
mining stillbirth outcome (31/32, 97%). Twenty studies 
had a low risk of misclassification bias for assessment 
of gestational age (20/32, 63%) and determination of 
chorionicity (25/32, 78%).
stillbirth and neonatal mortality beyond 34 weeks’ 
gestation
Dichorionic twin pregnancies
The prospective risk of stillbirth was 1.2 per 1000 preg-
nancies (95% confidence interval 0.7 to 1.8) at 34+0-6 
weeks, with the corresponding risk of neonatal death of 
6.7 per 1000 pregnancies (3.3 to 13.5) (table 1). The risk 
of stillbirth was significantly lower than the risk of neo-
natal death at 34+0-6 weeks (risk difference −5.8/1000, 
−10.4 to −1.2/1000; I2=0%) and 35+0-6 weeks (−5.1/1000, 
−8.7 to −1.6/1000; I2=0%). The perinatal risks were bal-
anced at 37+0-6 weeks (1.2/1000, −1.3 to 3.6/1000; 
I2=0%), beyond which the risks of stillbirth (10.6, 7.1 to 
15.3) significantly outweighed the risk of neonatal death 
(1.5/1000, 0.7 to 3.3) from delivery (risk difference 
8.8/1000, 3.6 to 14/1000; I2=0%) (fig 3). Analysis in 
which we excluded fetuses with congenital abnormali-
ties showed results similar to the main analysis (appen-
dix 4). Exclusion of studies with low external validity 
showed a trend towards an increased risk of stillbirth 
rather than an increased risk of neonatal death beyond 
37+0-6 weeks, which was not significant.
Monochorionic twin pregnancies
At 34 weeks, the prospective risk of stillbirth and neona-
tal mortality rates in monochorionic pregnancies were 
0.9 (95% confidence interval 0.1 to 3.4) and 12.1 (4.2 to 
34.3), respectively. The risks of neonatal death were 
higher than the risks of stillbirth at 34+0-6 (risk differ-
ence −15.6/1000, 95% confidence interval −40.4 to 
9.1/1000; I2=0%) and 35+0-6 weeks (−2.4/1000, −17.6 to 
12.8/1000; I2=0%), which were not significant (fig 3). 
Beyond 36+0-6 weeks, we observed a trend where the 
risk of stillbirth (9.6/1000, 3.9 to 19.7) was higher than 
the risk of neonatal death (3.6/1000, 1.2 to 11.1) with a 
risk difference of 2.5/1000 (−12.4 to 17.4/1000; I2=0%). 
Sensitivity analysis in which we excluded studies with 
congenitally malformed fetuses (appendix 4) and stud-
ies with low external validity showed similar findings.
All analyses were restricted up to 38 weeks for mono-
chorionic twin pregnancies and up to 39 weeks for 
dichorionic twin pregnancies because of the lack of 
availability of robust data beyond this period.
neonatal morbidity beyond 34 weeks’ gestation
We observed a consistent and significant reduction in 
the rates of assisted ventilation, respiratory distress 
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Fig 2 | risk of bias in studies included in systematic review on prospective risk of stillbirth 
and neonatal complications in uncomplicated twin pregnancies
table 1 | Prospective risk of stillbirth and risk of neonatal death in weekly intervals in uncomplicated dichorionic and monochorionic twin pregnancies 
from 34 weeks’ gestation
gestational age (weeks)
no of stillbirths/
no of ongoing 
pregnancies
Crude risk of stillbirth 
(per 1000 pregnancies) 
(95% Ci)
no of neonatal 
deaths/no of 
women delivered
risk of neonatal death* 
(per 1000 pregnancies) 
(95% Ci)
Pooled risk difference† 
(per 1000 pregnancies) 
(95% Ci)
Dichorionic twin pregnancies (15 studies)
34+0-6 21/17 830 1.2 (0.7 to 1.8) 12/1742 6.7 (3.3 to 13.5) −5.8 (−10.4 to −1.2)
35+0-6 12/15 470 0.8 (0.4 to 1.4) 15/2611 4.6 (2.4 to 8.7) −5.1 (−8.7 to −1.6)
36+0-6 18/11 824 1.5 (0.9 to 2.4) 12/4238 3.2 (1.7 to 5.9) −1.3 (−3.6 to 0.9)
37+0-6 23/6824 3.4 (2.1 to 5.1) 10/5141 2.2 (1.1 to 4.3) 1.2 (−1.3 to 3.6)
38+0-6 28/2633 10.6 (7.1 to 15.3) 5/2581 1.5 (0.7 to 3.3) 8.8 (3.6 to 14.0)
39+0-6 7/752 9.3 (3.8 to 19.1) 3/751 1.1 (0.4 to 2.6) 3.8 (−8.5 to 16.1)
monochorionic twin pregnancies (13 studies)
34+0-6 2/2149 0.9 (0.1 to 3.4) 4/247 12.1 (4.2 to 34.3) −15.6 (−40.4 to 9.1)
35+0-6 5/1797 2.8 (0.9 to 6.5) 2/367 8.1 (3.4 to 19.3) −2.4 (−17.6 to 12.8)
36+0-6 6/1325 4.5 (1.7 to 9.8) 3/534 5.4 (2.2 to 13.3) −1.5 (−14.4 to 11.4)
37+0-6 7/730 9.6 (3.9 to 19.7) 4/532 3.6 (1.2 to 11.1) 2.5 (−12.4 to 17.4)
38+0-6 2/264 7.6 (0.9 to 27.1) 0/307 2.4 (0.6 to 10.3) 7.0 (−19.7 to 33.7)
*Risk of neonatal death computed by multilevel logistic regression model (see text).
†Individual studies risk differences pooled by fixed effect model meta-analysis (see text).
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syndrome, admission to neonatal intensive care unit, 
and septicaemia with increasing gestational age in 
babies of both monochorionic and dichorionic twin 
pregnancies (table 2). Admission to neonatal intensive 
care was the commonest complication in monochori-
onic and dichorionic twin pregnancies.
stillbirth and neonatal outcomes in early preterm 
twin pregnancies
The cumulative risks of stillbirth and risks of neonatal 
deaths by two weekly gestational periods in early 
preterm twin pregnancies (gestation 26+0 to 33+6) are 
provided in appendix 5. Early preterm neonatal 
 outcomes in two weekly time periods are shown in 
appendix 6. Neonatal morbidity reduced with increas-
ing gestational age in all twin pregnancies. In both 
monochorionic and dichorionic pregnancies, the most 
common neonatal complications were respiratory dis-
tress syndrome, septicaemia, admission to neonatal 
intensive care unit and need for assisted ventilation.
Publication bias and small studies effect
Funnel plots showed a slight asymmetry for stillbirth 
outcome in dichorionic pregnancies (Peter’s test 
P=0.037), consistent with the  finding that smaller 
 studies are published if they show higher rates of still-
birth. We found no more significant asymmetries for 
outcome of neonatal death.
discussion
In dichorionic twin pregnancies the perinatal risks are 
balanced until 37+0-6 weeks’ gestation, and until 
36+0-6 in monochorionic pregnancies, with higher 
risks of stillbirths than neonatal deaths beyond this 
gestation. Our study provides comprehensive estimates 
comparing risks of stillbirth and neonatal mortality at 
various gestational ages, which is required for the plan-
ning of delivery in uncomplicated twin pregnancies.
strengths and limitations
This was the largest and most robust systematic review 
to date on stillbirths and neonatal outcomes in twin 
pregnancies. In addition to the risk of stillbirth at each 
gestational week, we provided risk estimates of the 
other equally important consequence of early delivery—
namely, neonatal death. Ours is the first review to pro-
vide estimates of neonatal morbidity for specific 
chorionicity and gestational age in twin pregnancies. 
All the included studies were relatively recent and pub-
lished within the past 10 years. The sharing of unpub-
lished aggregate and individual patient data by authors 
enabled us to provide our findings in clinically relevant 
weekly intervals. We chose the gestational timeframes 
to reduce bias from varied lengths of follow-up. We min-
imised heterogeneity by excluding studies without 
clear details on twin-to-twin transfusion syndrome. Our 
sensitivity analyses allowed us to assess the risks in 
pregnancies not complicated by congenital malforma-
tion and by fetal growth restriction.
Our findings were limited by the policy of planned 
delivery beyond 37 and 38 weeks’ gestation in most stud-
ies. This reduced the available sample size near term, 
particularly in monochorionic pregnancies, and could 
have led to underestimation of risk of stillbirth in the last 
weeks of pregnancy. Although the observed increased 
risk of stillbirth was higher than the increased risk of 
neonatal death beyond 36 weeks in monochorionic 
pregnancies, the differences were not significant. This 
was because of the gradual decline in the number of 
pregnancies available for analysis, which could be 
attributed to the policy of elective delivery near term. 
Most studies did not provide details on whether still-
birth was diagnosed antenatally or at birth. Given the 
policy of regular ultrasound for fetal monitoring in most 
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Fig 3 | Prospective risks of stillbirths from expectant management compared with risks 
of neonatal mortality from delivery at weekly intervals from 34 weeks’ gestation in twin 
pregnancies
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units, however, we expect the interval between 
 diagnosis and delivery to be small. The variation 
observed in the clinical management of twin pregnan-
cies and neonatal care after delivery between centres 
could also have influenced the outcomes.59 The small 
study effects that we observed for stillbirth outcomes in 
monochorionic pregnancies could be attributed to selec-
tive reporting or publication of data from centres show-
ing good outcomes and small sample sizes. We ensured 
that all data were available from 34 weeks for women in 
randomised trials, but it is possible that women with 
early stillbirth would not be in the analysis.
We undertook a pragmatic approach by including all 
twin pregnancies not complicated by twin to twin trans-
fusion syndrome. We were not able to provide separate 
estimates for individual causes of neonatal mortality or 
for elective and emergency deliveries. The results did 
not vary after we excluded pregnancies complicated by 
fetal growth restriction, one of the main indications for 
emergency delivery. We focused only on short term neo-
natal morbidity because of paucity of data.60 61 We pro-
vided the risk estimates per pregnancy and not per 
fetus, as it is likely that mothers would consider the 
prospective risk of death in either of their fetuses in 
utero or after delivery to be equally important. This, 
however, limited our ability to distinguish between 
those pregnancies with a single or double adverse 
 outcome.
Primary studies,15 16 29 39 62  systematic reviews,13  and 
guideline bodies9 63  have been limited in their interpre-
tation of evidence on the timing of delivery in twin preg-
nancies because of paucity of data and inadequate 
methods. Firstly, they compared the risks of stillbirth in 
twin pregnancies at various gestational weeks with 
those at, or near, term, without considering the inher-
ent longitudinal design with women repeatedly 
observed during the pregnancy.64  Secondly, some stud-
ies estimated risk using survival analysis (Kaplan-Meier 
method). Delivery was not considered as a competing 
event for the outcome of stillbirth and might have over-
estimated the risk.65  Thirdly, studies did not provide 
gestational age specific pooled estimates for significant 
neonatal morbidity.13 66  Fourthly, existing recommen-
dations on the timing of delivery are based on gesta-
tional age specific risk of stillbirth and do not formally 
take into account the benefit gained by reducing neona-
tal deaths.13 67  Finally, the risks of fetal death in twins 
were not assessed beyond 36 weeks’ gestation, and the 
rationale behind the choice of the gestational ages for 
elective delivery is not clear.9  Other large epidemiolog-
ical studies on perinatal outcomes in twins were limited 
by the lack of detail regarding the chorionicity and 
the  definition of uncomplicated monochorionic 
 pregnancies.68 69
implications of findings
Some current recommendations offer expectant man-
agement of uncomplicated dichorionic twin pregnan-
cies until 38+0-6.8 10  Based on our findings, this poses a 
risk of an additional 8.8 perinatal deaths compared 
with delivery a week earlier. Although we observed a 
change in the direction of the difference in risk, with 
more stillbirths than neonatal deaths beyond 36 weeks 
in monochorionic twin pregnancies, the difference was 
not significant. The variation in policies for manage-
ment of monochorionic twin pregnancies, with some 
advocating delivery as early as 34+0-6 weeks,8 10  have 
contributed to the fall in number of pregnancies avail-
able for analysis in later gestation. Based on our find-
ings, there is no clear evidence to recommend early 
preterm delivery routinely before 36 weeks in monocho-
rionic pregnancies. The information on risks provided 
in twin pregnancies will complement the ongoing 
national and international efforts to reduce the rates of 
stillbirths70 and unexpected neonatal complications in 
babies born near term.
With a 10th of all twin pregnancies delivering before 
32 weeks, our estimates on early preterm neonatal 
table 2 | individual neonatal morbidity outcomes in monochorionic and dichorionic twin pregnancies after 34 weeks’ gestation
gestational 
age
assisted ventilation
hypoxic ischaemic 
encephalopathy or 
neonatal seizures
respiratory distress 
syndrome (rDs) septicaemia niCu admission
n/n risk* (95% Ci) n/n risk* (95% Ci) n/n risk* (95% Ci) n/n risk* (95% Ci) n/n risk* (95% Ci)
monochorionic
No of studies 7 — 7 — 10 — 11 — 9 —
34+0-34+6 23/143 112.9 (49.2 to 238.3) 0/101 N/A 38/178 176.7 (105.2 to 281.5) 9/196 54.3 (23.9 to 118.8) 61/157 501.6 (306.1 to 696.6)
35+0-35+6 17/206 61.3 (26.9 to 133.3) 0/144 N/A 22/261 74.2 (43.6 to 123.7) 7/283 24.4 (11.7 to 50.5) 61/229 316.8 (173.2 to 506.6)
36+0-36+6 14/289 32.4 (13.7 to 74.3) 1/238 N/A 13/365 29.1 (15.9 to 52.5) 3/406 10.8 (4.6 to 24.9) 44/319 176.1 (88.0 to 321.4)
37+0-37+6 7/308 16.9 (6.6 to 42.5) 0/242 N/A 9/424 11.1 (5.3 to 22.8) 3/452 4.7 (1.6 to 14.1) 34/345 89.7 (41.3 to 183.9)
38+0-38+6 2/163 8.7 (3.0 to 25.0) 0/137 N/A 0/225 4.2 (1.7 to 10.2) 0/237 2.1 (0.5 to 8.5) 5/168 43.4 (18.4 to 99.3)
Dichorionic
No of studies 9 — 2 — 13 — 11 — 11 —
34+0-34+6 75/372 97.3 (36.4 to 235.4) 1/190 3.6 (0.7 to 19.7) 94/490 130.1 (77.8 to 209.6) 11/465 9.5 (2.4 to 36.1) 181/401 492.6 (317.4 to 669.6)
35+0-35+6 72/518 56.8 (20.9 to 145.6) 1/304 2.8 (0.9 to 9.2) 63/695 69.3 (40.9 to 114.9) 6/659 6.4 (1.7 to 23.5) 179/577 315.4 (182.3 to 487.8)
36+0-36+6 69/779 32.6 (11.8 to 86.9) 1/530 2.2 (0.9 to 5.3) 49/1013 35.7 (20.8 to 60.8) 10/943 4.3 (1.2 to 15.7) 152/853 179.5 (95.9 to 310.9)
37+0-37+6 41/1146 18.5 (6.5 to 51.0) 1/820 1.7 (0.6 to 4.8) 46/1563 18.1 (10.2 to 31.8) 8/1447 2.9 (0.8 to 10.9) 154/1296 94.1 (47.7 to 177.2)
38+0-38+6 21/834 10.4 (3.6 to 29.7) 0/601 1.3 (0.3 to 5.9) 17/1120 9.1 (4.9 to 16.7) 7/1081 2.0 (0.5 to 7.8) 77/932 47.0 (22.9 to 94.0)
39+0-39+6 2/103 5.8 (2.0 to 17.3) 1/63 1.1 (0.1 to 8.2) 1/258 4.5 (2.3 to 8.8) 1/235 1.3 (0.3 to 5.8) 5/134 22.9 (10.8 to 47.9)
NICU=neonatal intensive care unit; n=No of adverse outcomes; N=No of women delivered in that 1 week gestational time period.
*Risk/1000 deliveries.
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 mortality and morbidity provide crucial information to 
counsel mothers at risk of early preterm delivery.71-73 
Our work has fulfilled the unmet needs in this specialty, 
in which current estimates on the predicted probability 
of survival of newborns, especially early preterm twins, 
are based on extrapolated data from small samples and 
do not take into account the effects of chorionicity.14 
Although we did not incorporate economic evaluation 
in our review, avoidance of early delivery has the 
 potential for huge savings to the healthcare system, 
with one study suggesting savings up to $70 000 
(£53 600, €63 000) per infant.62
The feasibility of a definitive randomised trial on 
optimal timing of delivery in twin pregnancies is lim-
ited, given the huge numbers needed to assess out-
comes.15 16  Individual patient data meta-analysis would 
allow us to assess the effect of factors such as monitor-
ing of the fetuses, level of newborn care, and mode of 
delivery on outcomes. There is a need to study the 
effects of delivery before 37 weeks and the loss of a 
co-twin in monochorionic pregnancies on long term 
infant neurodevelopment.61 74 75
Conclusion
For women with dichorionic pregnancies, delivery 
should be considered at 37 weeks’ gestation to minimise 
the risk of perinatal deaths near term. There is insuffi-
cient evidence to recommend routine delivery before 36 
weeks’ gestation in monochorionic twins. Our estimates 
of fetal and neonatal outcomes at various gestational 
ages in twin pregnancies should be taken into account 
when decisions are made on timing of delivery.
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